Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world prospective non-interventional study of remimazolam tosilate for sedation during gastroscopy and colonoscopy
CTR20220224Phase 4Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam in procedural sedation and analgesia (PSA), sponsored by Hengrui Therapeutics. Started Jan 2022; status: completed.
02
Drugs
remimazolam
03
Conditions
procedural sedation and analgesia (PSA)
Beyond the preview
Go deeper on CTR20220224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220224.